Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients
Authors
Keywords
FGF23, Hemodialysis, Hepcidin, Phosphate binders
Journal
Clinical and Experimental Nephrology
Volume 21, Issue 5, Pages 908-916
Publisher
Springer Nature
Online
2016-12-07
DOI
10.1007/s10157-016-1362-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative Effectiveness of Calcium Acetate and Sevelamer on Clinical Outcomes in Elderly Hemodialysis Patients Enrolled in Medicare Part D
- (2014) Akeem A. Yusuf et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients
- (2014) Hsin-Hung Lin et al. NEPHROLOGY
- Effects of Dietary Phosphate Restriction and Phosphate Binders on FGF23 Levels in CKD
- (2013) T. Isakova et al. Clinical Journal of the American Society of Nephrology
- The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients
- (2013) Sagrario Soriano et al. CLINICAL NEPHROLOGY
- Calcium Regulates FGF-23 Expression in Bone
- (2013) Valentin David et al. ENDOCRINOLOGY
- Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis
- (2013) Sophie A Jamal et al. LANCET
- Effect of a Non-Calcium-Based Phosphate Binder on Fibroblast Growth Factor 23 in Chronic Kidney Disease
- (2013) Christin Spatz et al. NEPHRON CLINICAL PRACTICE
- Effects of Switching From Calcium Carbonate to Lanthanum Carbonate on Bone Mineral Metabolism in Hemodialysis Patients
- (2013) Rie Manabe et al. THERAPEUTIC APHERESIS AND DIALYSIS
- High dose intravenous iron, mineral homeostasis and intact FGF23 in normal and uremic rats
- (2013) Eva Gravesen et al. BMC Nephrology
- The effects of iron on FGF23-mediated Ca–P metabolism in CKD patients
- (2012) Serpil Muge Deger et al. Clinical and Experimental Nephrology
- Effect of lanthanum carbonate vs. calcium carbonate on serum calcium in hemodialysis patients: a crossover study
- (2012) Tatsunori Toida et al. CLINICAL NEPHROLOGY
- Calcium Deficiency Reduces Circulating Levels of FGF23
- (2012) M. E. Rodriguez-Ortiz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Comparison of Calcium Acetate and Sevelamer on Vascular Function and Fibroblast Growth Factor 23 in CKD Patients: A Randomized Clinical Trial
- (2011) Mahmut Ilker Yilmaz et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effect of Intravenous Saccharated Ferric Oxide on Serum FGF23 and Mineral Metabolism in Hemodialysis Patients
- (2011) Yoko Takeda et al. AMERICAN JOURNAL OF NEPHROLOGY
- Hepcidin and disordered mineral metabolism in chronic kidney disease
- (2011) C. Carvalho et al. CLINICAL NEPHROLOGY
- Combined therapy with lanthanum carbonate and calcium carbonate for hyperphosphatemia decreases serum FGF-23 level independently of calcium and PTH (COLC Study)
- (2011) T. Shigematsu et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients
- (2011) E. Gonzalez-Parra et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The Suppressive Effects of Lanthanum on the Production of Inflammatory Mediators in Mice Challenged by LPS
- (2010) Fei Guo et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study
- (2010) V. M. Brandenburg et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast Growth Factor 23 in Hemodialysis Patients: Effects of Phosphate Binder, Calcitriol and Calcium Concentration in the Dialysate
- (2010) Ana L.E. Cancela et al. NEPHRON CLINICAL PRACTICE
- Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Mineral Metabolism and Inflammation in Chronic Kidney Disease Patients: A Cross-Sectional Study
- (2009) J. F. Navarro-Gonzalez et al. Clinical Journal of the American Society of Nephrology
- Hepcidin for Clinicians
- (2009) B. Young et al. Clinical Journal of the American Society of Nephrology
- Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
- (2009) R. B. Oliveira et al. Clinical Journal of the American Society of Nephrology
- Lanthanum Acetate Inhibits Vascular Calcification Induced by Vitamin D3 Plus Nicotine in Rats
- (2009) Ye-Bo Zhou et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin
- (2009) Mohga M. El-Abbadi et al. KIDNEY INTERNATIONAL
- Relationship between circulating FGF23 and total body atherosclerosis in the community
- (2009) Majd A. I. Mirza et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Short-Term Treatment with Sevelamer Increases Serum Fetuin-A Concentration and Improves Endothelial Dysfunction in Chronic Kidney Disease Stage 4 Patients
- (2007) K. Caglar et al. Clinical Journal of the American Society of Nephrology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search